Search results for: 'Tissue Diagnostics Market,'
- Related search terms
- diagnostics markets philippines
- diagnostics market outlook series
- diagnostics market outlook services
- diagnostics market analysi
- diagnostics market philippines
-
26 Aug 2024  |  Global  |  Market Research
Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029
Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth
The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development. According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040,...
$4,950.00
Special Price $4,207.50 save 15 %
-
25 Mar 2026  |  Global  |  Market Research
Global Clinical Diagnostics Industry Growth Opportunities, 2026–2031
Next-Gen AI-Integrated Biomarkers and Smart Automation are Advancing Precision and Early Detection in Molecular and Point-of-Care Diagnostics
The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...
$4,950.00 -
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
22 Apr 2024  |  Global  |  Market Research
Global Molecular Diagnostics Market, Forecast to 2029
Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine
The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities. Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-gen...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Jan 2024  |  Global  |  Market Research
Top 5 Growth Opportunities for Clinical Diagnostics, 2024
Enabling Precision Health Journey Through Omics, Digital Diagnostics Services, and Smart Screening Solutions
Clinical diagnostics is undergoing a radical shift, driven by omics integration for precision health, digital diagnostics services, and smart screening solutions. Digital diagnostics are streamlining data analysis and communication, and enhancing overall efficiency. Smart screening, powered by AI and machine learning, is ensuring early and accurate...
$2,450.00
Special Price $1,837.50 save 25 %
-
18 Apr 2024  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2024
Driven by Digital Services and Automation, the Molecular Diagnostics and POCT Sectors Rebound after the COVID-19 Pandemic
With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare and precision medicine, as the clinical diagnostics industry continues its transition from a centralized to a decentralized testing model. Globally, 2024 is set to be a profitable year for the industry, which will ...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Aug 2026  |  Global  |  Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
Rapid Molecular Platforms, AI-Powered Workflows, Home-Based Testing, and Connected Care Models to Drive Decentralized Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...
$4,950.00 -
27 Jun 2023  |  Global  |  Frost Radar
Frost Radar™: Soft Tissue Navigation Systems, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Robot-assisted surgery offers significant promise in driving down treatment costs and addressing the healthcare industry’s increasing burden of lifestyle-related diseases and demand for affordable care. Next-generation surgical robotics technology and surgical navigation systems complement and extend surgeons’ ability to minimize surgical variabili...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2023  |  Global  |  Market Research
Global Tissue-engineered Skin Substitute Growth Opportunities
Breakthrough Technologies and Competitive Intensity Drive Innovation
Rising incidents of burn injuries, road accidents, and other trauma injuries, along with increasing cases of chronic wounds, such as diabetic ulcers and venous ulcers, are boosting the global tissue-engineered skin substitutes (TESS) market. Moreover, the increasing number of surgical injuries, plastic surgeries, cosmetic surgeries, and other recon...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Aug 2026  |  Global  |  Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...
$4,950.00